WeVote

Bill

Bill

HB 2291

opioids; containers; labeling; requirements; repeal

57th Legislature - First Regular Session Introduced by Walt Blackman

Arizona law modifies opioid container labeling requirements and repeals certain existing standards, effective immediately upon governor's signature.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 2291

Legislative bill overview

HB 2291 modifies Arizona's requirements for opioid medication container labeling and reportedly repeals certain existing labeling mandates. The bill, sponsored by Rep. Walt Blackman, was signed into law on April 7, 2025, after passing the legislature in early April.

Why is this important

Opioid labeling requirements affect medication safety, patient understanding of risks, and accidental overdose prevention—particularly for children and vulnerable populations. Changes to these standards can either strengthen or weaken consumer protections depending on what requirements were repealed versus added.

Potential points of contention

  • Clarity on repealed provisions: The bill title indicates repeals but doesn't specify which existing labeling requirements were eliminated, making it unclear whether consumer protections were reduced or streamlined
  • Public health alignment: Opioid safety advocates may question whether reduced labeling requirements conflict with overdose prevention goals, especially given the ongoing opioid crisis
  • Enforcement and compliance: Changes to labeling standards may create confusion for pharmacies and manufacturers about what labels must contain

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.